A fixed calorie deficit was selected over other methods (fixed body weight reduction or % calorie deficit) based on data from a validated mathematical model of human metabolism (24,25), suggesting more consistent change of body weight, FFM and FM in people with disparate body weight
Most calcitonin assessments were below the upper normal limit during the 2-year trial period, and no differences in mean concentrations were observed between liraglutide 2.4/3.0 mg and orlistat by logistic regression (estimated odds ratio for liraglutide 2.4/3.0 mg versus orlistat was 0.5 (95% confidence interval 0.171.6)
References GLP-1 Agonists: Mechanisms to Applications Wilding JPH, Batterham RL, Calanna S, et al
Who is eligible for Wegovy in the UK
However, compounded semaglutide lacks the rigorous testing and approval processes that FDA-approved medications undergo
Further Perspectives and Conclusions The expanding use of GLP-1 receptor agonists offers a great deal of potential for transforming public health approaches to obesity and type 2 diabetes management
